- Home
- CCEL vs FTHM Comparison
CCEL vs FTHM Comparison
Compare CCEL & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCEL | FTHM |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.8M | 37.9M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CCEL | FTHM |
|---|---|---|
| Price | $4.12 | $1.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 3.8K | ★ 173.4K |
| Earning Date | 10-15-2025 | 11-11-2025 |
| Dividend Yield | ★ 10.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $31,747,500.00 | ★ $421,612,000.00 |
| Revenue This Year | $0.30 | $30.07 |
| Revenue Next Year | N/A | $14.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 32.78 |
| 52 Week Low | $3.57 | $0.65 |
| 52 Week High | $8.86 | $3.37 |
Technical Indicators
Market Signals| Indicator | CCEL | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 43.02 |
| Support Level | $4.04 | $1.16 |
| Resistance Level | $4.08 | $1.25 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 62.79 | 48.28 |
Price Performance
Historical ComparisonAbout CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.